companydata.dkY-mAbs Therapeutics A/S: Financial statements 2022
CVR: 37053678
Y-mAbs Therapeutics A/S (CVR 37053678) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 82,332,358 and a net result of DKK -85,685,825 compared with DKK -42,087,769 the year before. That is an increase of 21.9% compared with the year before. Equity amounted to DKK -84,940,941. The company had 101 employees in the financial year.
- Gross Profit
- 82,332,358 kr.
- Profit/Loss
- -85,685,825 kr.
- Equity
- -84,940,941 kr.
- Total Assets
- 22,905,762 kr.
- Employees
- 101
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 82.3 mio. | -85.7 mio. | -84.9 mio. | 101 |
| 2021 | - | 67.5 mio. | -42.1 mio. | -39.3 mio. | 88 |
| 2020 | - | 82.4 mio. | -1.2 mio. | 2.8 mio. | 62 |
| 2019 | - | 52 mio. | -2.6 mio. | 4 mio. | 36 |
| 2018 | - | 28.6 mio. | -4.2 mio. | 1.6 mio. | 19 |
Keep an eye on Y-mAbs Therapeutics A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Y-mAbs Therapeutics A/S has published its annual report for 2021. Gross profit came to DKK 67,549,569, and the net result was DKK -42,087,769.
As of May 12, 2022, Johan Ernst Wedell-Wedellsborg has joined the board of directors of Y-mAbs Therapeutics A/S.
As of May 12, 2022, Thomas Gad has joined the board of directors of Y-mAbs Therapeutics A/S.
As of May 12, 2022, Bo Kruse has joined the board of directors of Y-mAbs Therapeutics A/S.
As of May 12, 2022, Claus Juan Møller-San Pedro has left the board of directors of Y-mAbs Therapeutics A/S.
As of May 12, 2022, Thomas Gad is registered as adm. dir. of Y-mAbs Therapeutics A/S.
As of May 12, 2022, Claus Juan Møller-San Pedro has stepped down as director of Y-mAbs Therapeutics A/S.
As of May 11, 2022, Thomas Gad has left the board of directors of Y-mAbs Therapeutics A/S.
As of May 11, 2022, Bo Kruse has left the board of directors of Y-mAbs Therapeutics A/S.
About Y-mAbs Therapeutics A/S
Y-mAbs Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Vincent Sainte-Catherine. The company is owned by Y-mAbs Therapeutics, Inc.. The company has 24 employees. In 2025, the company reported a gross profit of DKK 29,300,371 and a net result of DKK -38,461,598 compared with DKK -12,500,464 the year before. Equity amounted to DKK -163,651,844.